Sociedad Americana de Hirudoterapia

Identification and characterization of a novel neuropeptide (neuropeptide Y-HS) from leech salivary gland of Haemadipsa sylvestris

Basic science published in Chin J Nat Med (2016)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Farmacología salivalGenómica y proteómicaLiu WH et al. · Chinese journal of natural medicines, 2016

Abstract

The present study was designed to identify immunomodulatory components from the leech salivary gland of Haemadipsa sylvestris. The Sephadex G-50, Resource(TM) S column chromatography and reverse-phase high performance liquid chromatography (RP-HPLC) were used to isolate and purify the salivary gland extracts (SGE). Structural analysis of isolated compounds was based on Edman degradation and matrix assisted laser desorption ionization time-of-flight mass spectrometer (MALDI-TOF-MS). The cDNA encoding the precursor of the compound was cloned from the cDNA library of the salivary gland of H. sylvestris. The levels of inflammatory mediators, including tumor necrosis factor-α (TNF-α), interferon γ (IFN-γ), interleukin-6 (IL-6), and monocyte chemotactic protein-1 (MCP-1) were assayed using an enzyme-linked immunosorbent assay (ELISA). The effects on cell proliferation and cell viability were observed using MTT assay. A novel neuropeptide Y (Neuropeptide Y-HS) from the leech salivary gland of H. sylvestris was purified and characterized. It was composed of 36 amino acid residues and the amino acid sequence was determined to be FLEPPERPAVFTSVEQMKSYIKALNDYYLLLGRPRF-NH2, containing an amidated C-terminus. It showed significant inhibitory effects on the production of inflammatory cytokines including TNF-α, IFN-γ, IL-6, and MCP-1. Neuropeptide Y was identified from leeches for the first time. The presence of neuropeptide Y-HS in leech salivary gland may help get blood meal from hosts and inhibit inflammation.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAmino Acid SequenceAnimalsImmunologic FactorsInflammationInterferon-gammaInterleukin-6LeechesMass SpectrometryMiceMolecular Sequence DataNeuropeptide YPeptide Mapping

Resumen

Novel 36-amino-acid amidated neuropeptide Y-HS from H. sylvestris salivary gland inhibits TNF-alpha, IFN-gamma, IL-6, and MCP-1, suggesting blood-feeding immunomodulation.

Por qué esto importa para la hirudoterapia

This study isolated and characterized a novel 36-amino-acid neuropeptide Y (Neuropeptide Y-HS) from salivary glands of the haematophagous leech Haemadipsa sylvestris, determined its sequence and amidated C-terminus, and showed inhibitory effects on production of TNF-α, IFN-γ, IL-6, and MCP-1 in an ELISA-based assay, with MTT assays for proliferation/viability. For ASH, this is relevant as a characterization of an immunomodulatory component of a leech salivary gland, potentially relevant to how leeches suppress host inflammation while feeding. The caveat is that H. sylvestris is not a standard medicinal leech used in hirudotherapy, and the anti-inflammatory effects are shown in vitro only with no whole-animal, in-vivo, or clinical validation; the host-blood-meal rationale posited is interpretive, not directly demonstrated.

Citación

Identification and characterization of a novel neuropeptide (neuropeptide Y-HS) from leech salivary gland of Haemadipsa sylvestris.

Liu WH et al. · Chinese journal of natural medicines, 2016

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.